You are here

Victoza

ADA: Lilly's Trulicity bests Novo's Victoza, AZ's Bydureon in real-world study

Fierce Pharma

Mon, 06/25/18 - 09:07 pm

Novo Nordisk's oral semaglutide impresses analysts against Victoza, Januvia

Fierce Pharma

Thu, 06/21/18 - 10:58 pm

GLP-1 Drug Class May Continue to Drive Growth for Novo Nordisk

Market Realist

Mon, 03/5/18 - 09:24 am

NovoNordisk’s CSO openly addresses state of pharma sector

GoinPharma

Fri, 12/1/17 - 11:41 am

PCSK9 inhibitors

Humira back on top of TV spending list for October, ahead of Lyrica and Victoza

Fierce Pharma

Mon, 11/6/17 - 10:12 am

Nordisk settles DOJ’s Victoza marketing suit for $59m

Drug Delivery Business News

Wed, 09/6/17 - 10:40 am

Novo’s Victoza, new indication to reduce CV risk

GoInPharma

Sun, 08/27/17 - 06:24 pm

cardiovascular disease

FDA clears Novo Nordisk's diabetes drug to reduce cardiovascular risk

Yahoo/Reuters

Sat, 08/26/17 - 11:56 am

Novo Nordisk leans on Victoza as competition increases

BioPharma Dive

Wed, 08/9/17 - 03:09 pm

For diabetes drugs, lowering blood sugar may no longer be enough to stay competitive

Medical Marketing and Media

Thu, 06/22/17 - 09:32 am

FDA panel supports cardiovascular indication for Novo’s diabetes drug Victoza

Fierce Pharma

Tue, 06/20/17 - 10:53 pm

advisory panels

Top 10 diabetes drugs by 2016 sales

Fierce Pharma

Thu, 06/8/17 - 10:04 am

AZ's Bydureon cleared a heart safety test, but didn't cut risks. Can it still vie with Novo?

Fierce Pharma

Tue, 05/23/17 - 08:17 am

Novo’s diabetes medication Victoza keeps growing, despite Lilly’s market-share creep

Fierce Pharma

Thu, 05/4/17 - 10:08 am

Teva Confirms Generic Victoza® Patent Challenge in the United States

Yahoo

Thu, 02/2/17 - 09:20 am

Teva Pharmaceutical

ADA guidelines highlight new Jardiance label

BioPharma Dive

Mon, 12/19/16 - 11:39 am

Boehringer Ingelheim

Novo Nordisk: Why The Diabetes Giant Will Continue To Grow

Seeking Alpha

Tue, 12/13/16 - 10:14 am

Novo’s Victoza Diabetes Medicine Rebuffed by Express Scripts

Bloomberg

Tue, 08/2/16 - 08:50 am

Express Scripts

Diabetes sales rocket toward $60B, with Novo and Lilly's GLP-1s first in line for growth

Fierce Pharma

Mon, 07/11/16 - 09:15 am

What Is It About Novo Nordisk's Diabetes Drug That Makes It a Top Seller?

Motley Fool

Mon, 06/20/16 - 10:27 am

Pages